IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-60395-z.html
   My bibliography  Save this article

From precision interventions to precision health

Author

Listed:
  • Nicholas J. Schork

    (a part of the City of Hope National Medical Center
    The City of Hope National Medical Center
    University of California San Diego
    Scripps Research)

  • Laura H. Goetz

    (a part of the City of Hope National Medical Center
    Net.bio)

Abstract

Precision medicines, or those medicines that are tailored to individual genetic, molecular, physiologic, behavioral, and/or exposure profiles, are being developed at a rapid pace. However, just how precise these interventions are in terms of their mechanisms of action (MOAs), clinical effects, and utility in different individuals, are hard anticipate with current preclinical research and clinical trials strategies. To understand how various genes, processes, organs, clinical phenotypes, etc. may be impacted by an intervention, as well as how many people might benefit from it, appropriate data on living human beings needs to be collected as part of built-for-purpose clinical trials.

Suggested Citation

  • Nicholas J. Schork & Laura H. Goetz, 2025. "From precision interventions to precision health," Nature Communications, Nature, vol. 16(1), pages 1-11, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60395-z
    DOI: 10.1038/s41467-025-60395-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-60395-z
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-60395-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Mariana Lenharo, 2024. "Move over, CRISPR: RNA-editing therapies pick up steam," Nature, Nature, vol. 626(8001), pages 933-934, February.
    2. Xiaoyu Chen & Fikri Birey & Min-Yin Li & Omer Revah & Rebecca Levy & Mayuri Vijay Thete & Noah Reis & Konstantin Kaganovsky & Massimo Onesto & Noriaki Sakai & Zuzana Hudacova & Jin Hao & Xiangling Men, 2024. "Antisense oligonucleotide therapeutic approach for Timothy syndrome," Nature, Nature, vol. 628(8009), pages 818-825, April.
    3. Patrick A. Ott & Zhuting Hu & Derin B. Keskin & Sachet A. Shukla & Jing Sun & David J. Bozym & Wandi Zhang & Adrienne Luoma & Anita Giobbie-Hurder & Lauren Peter & Christina Chen & Oriol Olive & Todd , 2017. "An immunogenic personal neoantigen vaccine for patients with melanoma," Nature, Nature, vol. 547(7662), pages 217-221, July.
    4. Clare Bycroft & Colin Freeman & Desislava Petkova & Gavin Band & Lloyd T. Elliott & Kevin Sharp & Allan Motyer & Damjan Vukcevic & Olivier Delaneau & Jared O’Connell & Adrian Cortes & Samantha Welsh &, 2018. "The UK Biobank resource with deep phenotyping and genomic data," Nature, Nature, vol. 562(7726), pages 203-209, October.
    5. Yves Rolland & Felipe Sierra & Luigi Ferrucci & Nir Barzilai & Rafael Cabo & Joan Mannick & Anthony Oliva & William Evans & Davide Angioni & Philipe Souto Barreto & Jeremy Raffin & Bruno Vellas & Jame, 2023. "Challenges in developing Geroscience trials," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    6. Melinda Kliegman & Manar Zaghlula & Susan Abrahamson & Jonathan H. Esensten & Ross C. Wilson & Fyodor D. Urnov & Jennifer A. Doudna, 2024. "A roadmap for affordable genetic medicines," Nature, Nature, vol. 634(8033), pages 307-314, October.
    7. John C. Means & Anabel L. Martinez-Bengochea & Daniel A. Louiselle & Jacqelyn M. Nemechek & John M. Perry & Emily G. Farrow & Tomi Pastinen & Scott T. Younger, 2025. "Rapid and scalable personalized ASO screening in patient-derived organoids," Nature, Nature, vol. 638(8049), pages 237-243, February.
    8. Ilaria Bellantuono, 2018. "Find drugs that delay many diseases of old age," Nature, Nature, vol. 554(7692), pages 293-295, February.
    9. Andrea Di Francesco & Andrew G. Deighan & Lev Litichevskiy & Zhenghao Chen & Alison Luciano & Laura Robinson & Gaven Garland & Hannah Donato & Matthew Vincent & Will Schott & Kevin M. Wright & Anil Ra, 2024. "Dietary restriction impacts health and lifespan of genetically diverse mice," Nature, Nature, vol. 634(8034), pages 684-692, October.
    10. Lucy Allen & Lorna Allen & Siobhan B. Carr & Gwyneth Davies & Damian Downey & Marie Egan & Julian T. Forton & Robert Gray & Charles Haworth & Alexander Horsley & Alan R. Smyth & Kevin W. Southern & Ja, 2023. "Future therapies for cystic fibrosis," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    11. Nicholas J. Schork, 2024. "Dietary restriction can extend lifespan — but genetics matters more," Nature, Nature, vol. 634(8034), pages 555-556, October.
    12. Jinkuk Kim & Sijae Woo & Claudio M. Gusmao & Boxun Zhao & Diana H. Chin & Renata L. DiDonato & Minh A. Nguyen & Tojo Nakayama & Chunguang April Hu & Aubrie Soucy & Ashley Kuniholm & Jennifer Karlin Th, 2023. "A framework for individualized splice-switching oligonucleotide therapy," Nature, Nature, vol. 619(7971), pages 828-836, July.
    13. Nicholas J. Schork, 2015. "Personalized medicine: Time for one-person trials," Nature, Nature, vol. 520(7549), pages 609-611, April.
    14. Silvia Velasco, 2024. "Targeting RNA opens therapeutic avenues for Timothy syndrome," Nature, Nature, vol. 628(8009), pages 730-732, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Meghana Pagadala & Timothy J. Sears & Victoria H. Wu & Eva Pérez-Guijarro & Hyo Kim & Andrea Castro & James V. Talwar & Cristian Gonzalez-Colin & Steven Cao & Benjamin J. Schmiedel & Shervin Goudarzi , 2023. "Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    2. Matteo Di Scipio & Mohammad Khan & Shihong Mao & Michael Chong & Conor Judge & Nazia Pathan & Nicolas Perrot & Walter Nelson & Ricky Lali & Shuang Di & Robert Morton & Jeremy Petch & Guillaume Paré, 2023. "A versatile, fast and unbiased method for estimation of gene-by-environment interaction effects on biobank-scale datasets," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    3. Heng Du & Lei Zhou & Zhen Liu & Yue Zhuo & Meilin Zhang & Qianqian Huang & Shiyu Lu & Kai Xing & Li Jiang & Jian-Feng Liu, 2024. "The 1000 Chinese Indigenous Pig Genomes Project provides insights into the genomic architecture of pigs," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    4. Jacob Joseph & Chang Liu & Qin Hui & Krishna Aragam & Zeyuan Wang & Brian Charest & Jennifer E. Huffman & Jacob M. Keaton & Todd L. Edwards & Serkalem Demissie & Luc Djousse & Juan P. Casas & J. Micha, 2022. "Genetic architecture of heart failure with preserved versus reduced ejection fraction," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    5. Vincent Michaud & Eulalie Lasseaux & David J. Green & Dave T. Gerrard & Claudio Plaisant & Tomas Fitzgerald & Ewan Birney & Benoît Arveiler & Graeme C. Black & Panagiotis I. Sergouniotis, 2022. "The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    6. Natalie DeForest & Yuqi Wang & Zhiyi Zhu & Jacqueline S. Dron & Ryan Koesterer & Pradeep Natarajan & Jason Flannick & Tiffany Amariuta & Gina M. Peloso & Amit R. Majithia, 2024. "Genome-wide discovery and integrative genomic characterization of insulin resistance loci using serum triglycerides to HDL-cholesterol ratio as a proxy," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    7. Dick Schijven & Sourena Soheili-Nezhad & Simon E. Fisher & Clyde Francks, 2024. "Exome-wide analysis implicates rare protein-altering variants in human handedness," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    8. Zheng, Kaiming & Wang, Xiaoyuan & Ni, Debing, 2021. "Reciprocity information and wage personalization," China Economic Review, Elsevier, vol. 68(C).
    9. Gökberk Alagöz & Else Eising & Yasmina Mekki & Giacomo Bignardi & Pierre Fontanillas & Michel G. Nivard & Michelle Luciano & Nancy J. Cox & Simon E. Fisher & Reyna L. Gordon, 2025. "The shared genetic architecture and evolution of human language and musical rhythm," Nature Human Behaviour, Nature, vol. 9(2), pages 376-390, February.
    10. Lili Liu & Atlas Khan & Elena Sanchez-Rodriguez & Francesca Zanoni & Yifu Li & Nicholas Steers & Olivia Balderes & Junying Zhang & Priya Krithivasan & Robert A. LeDesma & Clara Fischman & Scott J. Heb, 2022. "Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    11. Shahram Bahrami & Kaja Nordengen & Jaroslav Rokicki & Alexey A. Shadrin & Zillur Rahman & Olav B. Smeland & Piotr P. Jaholkowski & Nadine Parker & Pravesh Parekh & Kevin S. O’Connell & Torbjørn Elvsås, 2024. "The genetic landscape of basal ganglia and implications for common brain disorders," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    12. Marta Alcalde-Herraiz & JunQing Xie & Danielle Newby & Clara Prats & Dipender Gill & María Gordillo-Marañón & Daniel Prieto-Alhambra & Martí Català & Albert Prats-Uribe, 2024. "Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    13. repec:plo:pgen00:1009315 is not listed on IDEAS
    14. Sylvia Hartmann & Summaira Yasmeen & Benjamin M. Jacobs & Spiros Denaxas & Munir Pirmohamed & Eric R. Gamazon & Mark J. Caulfield & Harry Hemingway & Maik Pietzner & Claudia Langenberg, 2023. "ADRA2A and IRX1 are putative risk genes for Raynaud’s phenomenon," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    15. Elizabeth C. Goode & Laura Fachal & Nikolaos Panousis & Loukas Moutsianas & Rebecca E. McIntyre & Benjamin Yu Hang Bai & Norihito Kawasaki & Alexandra Wittmann & Tim Raine & Simon M. Rushbrook & Carl , 2024. "Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    16. Jujiao Kang & Yue-Ting Deng & Bang-Sheng Wu & Wei-Shi Liu & Ze-Yu Li & Shitong Xiang & Liu Yang & Jia You & Xiaohong Gong & Tianye Jia & Jin-Tai Yu & Wei Cheng & Jianfeng Feng, 2024. "Whole exome sequencing analysis identifies genes for alcohol consumption," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    17. Mit Shah & Marco H. A. Inácio & Chang Lu & Pierre-Raphaël Schiratti & Sean L. Zheng & Adam Clement & Antonio Marvao & Wenjia Bai & Andrew P. King & James S. Ware & Martin R. Wilkins & Johanna Mielke &, 2023. "Environmental and genetic predictors of human cardiovascular ageing," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    18. Mathias Seviiri & Matthew H. Law & Jue-Sheng Ong & Puya Gharahkhani & Pierre Fontanillas & Catherine M. Olsen & David C. Whiteman & Stuart MacGregor, 2022. "A multi-phenotype analysis reveals 19 susceptibility loci for basal cell carcinoma and 15 for squamous cell carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    19. Marie C. Sadler & Alexander Apostolov & Caterina Cevallos & Chiara Auwerx & Diogo M. Ribeiro & Russ B. Altman & Zoltán Kutalik, 2025. "Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    20. Zhaotong Lin & Wei Pan, 2024. "A robust cis-Mendelian randomization method with application to drug target discovery," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    21. Zhening Liu & Hangkai Huang & Jiarong Xie & Yingying Xu & Chengfu Xu, 2024. "Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank," Nature Communications, Nature, vol. 15(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60395-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.